Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.04 BRL | -2.09% |
|
-3.36% | +37.61% |
Jul. 01 | Colgate-Palmolive Company(NYSE:CL) added to Russell Top 200 Growth Index | CI |
Jul. 01 | Colgate-Palmolive Company(NYSE:CL) added to Russell 3000 Growth Index | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 27.64 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.3 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+37.61% | 79.62B | - | ||
+13.05% | 391B | C- | ||
+15.78% | 139B | B- | ||
-1.70% | 72.86B | A- | ||
-28.75% | 37.37B | B+ | ||
-15.37% | 34.89B | - | ||
+1.92% | 33.35B | B- | ||
+11.48% | 18.36B | A- | ||
+28.31% | 17.3B | B | ||
+14.10% | 13.38B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CL Stock
- COLG34 Stock
- Ratings Colgate-Palmolive Company